Adenosquamous inflammatory mammary carcinoma in bitch: Can CA 15-3, CRP and LDH improve prognosis?
DOI:
https://doi.org/10.33448/rsd-v11i3.26425Keywords:
Canine mammary tumor; Serum biomarkers ; Prognosis.Abstract
Inflammatory mammary carcinoma (IMC) is characterized by the presence of any subtype of aggressive carcinoma in association with an intense inflammatory reaction, in addition to the presence of tumor emboli. Considering IMC as a type of cancer with chronic inflammation, the complex relationship between inflammation, and alterations in cellular metabolism have highlighted the rationale assessment of cancer antigen 15-3 (CA 15-3), c-reactive protein (CRP), and lactate dehydrogenase (LDH). The present report had the objective to describe a rare case of adenosquamous carcinoma in mammary gland of a 10-year-old bitch, 7 kg, sexually intact, mixed-breed and how CA 15-3, CRP and LHD helped to determinate the clinical presentation of inflammatory carcinoma and the prognosis. Complete clinical staging, cell blood count and renal, and hepatic biochemistry was performed and did not reveal any significant abnormalities. CA 15-3 (9.46 IU/mL), CRP (5.3 mg/L), and LDH (287 U/L) were all above the references values reported by the literature. Although adenosquamous carcinoma of the mammary gland with inflammatory presentation in dogs is rare, the association of serum biomarkers could improve the patient's prognosis evaluation.
References
Campos, L. C., Lavalle, G. E., Estrela-Lima, A., Melgaço de Faria, J. C., Guimarães, J. E., Dutra, Á. P., Ferreira, E., de Sousa, L. P., Rabelo, É. M. L., Vieira da Costa, A. F. D., & Cassali, G. D. (2012). CA15.3, CEA and LDH in Dogs with Malignant Mammary Tumors. Journal of Veterinary Internal Medicine, 26(6), 1383–1388.
Campos, L. C., Silva, J. O., Santos, F. S., Araújo, M. R., Lavalle, G. E., Ferreira, E., & Cassali, G. D. (2015). Prognostic significance of tissue and serum HER2 and MUC1 in canine mammary cancer. Journal of Veterinary Diagnostic Investigation, 27(4), 531–535.
Carney, P. C., Ruaux, C. G., Suchodolski, J. S., Steiner, J. M. (2011). Biological variability of C-reactive protein and specific canine pancreatic lipase immunoreactivity in apparently healthy dogs. Journal of Veterinary Internal Medicine., 25(4), 825-30.
Cassali, G. D., Jark, P. C., Gamba, C., Damasceno, K. A., Estrela-Lima, A., De Nardi, A. B., Ferreira, E., Horta, R. S., Firmo, B. F., Sueiro, F. A. R., Rodrigues, L. C. S., & Nakagaki, K. Y. R. (2020). Consensus regarding the diagnosis, prognosis and treatment of canine and feline mammary tumors-2019. Brazilian Journal of Veterinary Pathology, 13(3), 555–574.
Cassali, G. D., Lavalle, G. E., Ferreira, E., Estrela-Lima, A., de Nardi, A. B., Ghever, C., Sobral, R. A., Amorim, R. L., Oliveira, L. O., Sueiro, F. A. R., Beserra, H. E. O., Bertagnolli, A. C., Gamba, C. O., Damasceno, K. A., Campos, C. B., Araujo, M. R., Campos, L. C., Monteiro, L. N., Nunes, F. C., … Torres, R. (2014). Consensus for the diagnosis, prognosis and treatment of canine mammary tumors-2013. Brazilian Journal of Veterinary Pathology, 7(2), 38–69.
Goldschmidt, M. H., Peña, L., Rasotto, R., & Zappulli, V. (2011). Classification and grading of canine mammary tumors. Veterinary Pathology, 48(1), 117–131.
Greghi, J. R., Fernandes, M. P., Groth, A., Silva, L. A. S., Schnitzer, J. F., Di Santis, G. W., Martins, M. I. M. (2021). Thermographic evaluation of piroxicam’s effect as an adjuvant treatment in canine mammary tumors. Research, Society and Development, 10(2), e18710212236.
Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of cancer: The next generation. Cell, 144(5), 646–674.
Kabel, A. M. (2017). Tumor markers of breast cancer: New prospectives. Journal of Oncological Sciences, 3(1), 5–11.
Kaneko, J. J., Harvey, J. W., Bruss, M. L. (2008). Clinical Biochemistry of Domestic Animals. 6th ed. San Diego: Academic Press.
Manuali, E., De Giuseppe, A., Feliziani, F., Forti, K., Casciari, C., Marchesi, M. C., Pacifico, E., Pawłowski, K. M., Majchrzak, K., & Król, M. (2012). CA 15-3 cell lines and tissue expression in canine mammary cancer and the correlation between serum levels and tumour histological grade. BMC Veterinary Research, 22(8), 86.
Peña, L., Gama, A., Goldschmidt, M. H., Abadie, J., Benazzi, C., Castagnaro, M., Díez, L., Gärtner, F., Hellmén, E., Kiupel, M., Millán, Y., Miller, M. A., Nguyen, F., Poli, A., Sarli, G., Zappulli, V., & de las Mulas, J. M. (2014). Canine Mammary Tumors: A Review and Consensus of Standard Guidelines on Epithelial and Myoepithelial Phenotype Markers, HER2, and Hormone Receptor Assessment Using Immunohistochemistry. Veterinary Pathology, 51(1), 127–145.
Planellas, M., Bassols, A., Siracusa, C., Saco, Y., Giménez, M., Pato, R., & Pastor, J. (2009). Evaluation of serum haptoglobin and C-reactive protein in dogs with mammary tumors. Veterinary Clinical Pathology, 38(3), 348–352.
Rasotto, R., Berlato, D., Goldschmidt, M. H., & Zappulli, V. (2017). Prognostic Significance of Canine Mammary Tumor Histologic Subtypes: An Observational Cohort Study of 229 Cases. Veterinary Pathology, 54(4), 571–578.
Ribeiro, T. A., Ferreira, V. R. F., Mondêgo-Oliveira, R., Andrade, F. H. E., Abreu-Silva, A. L., Oliveira, I. S., Melo, S. A., Teófilo, T. S., Torres, M. A. O. (2020). Epidemiological profile of canine neoplasms in São Luís/MA: a retrospective study (2008-2015). Research, Society and Development, 9(12), e8291210496.
Ryu, M. O., Kim, B. G., Choi, U. S., Baek, K. H., Song, Y. K., Li, Q., Seo, K. W., Ryeom, S., Youn, H. Y., & Bhang, D. H. (2019). Extracellular cyclic adenosine monophosphate-dependent protein kinase A autoantibody and C-reactive protein as serum biomarkers for diagnosis of cancer in dogs. Veterinary and Comparative Oncology, 17(1), 99–106.
Sorenmo, K. U., Worley, D. R., Zappulli, V. (2020). Tumors of the Mammary Gland. In: Vail DM, Thamm DH, Liptak JM, Small Animal Clincal Oncology. 6th ed. St. Louis: Elsevier.
Souza, C. H. M., Toledo-Piza, E., Amorin, R., Barboza, A., & Tobias, K. M. (2009). Inflammatory mammary carcinoma in 12 dogs: Clinical features, cyclooxygenase-2 expression, and response to piroxicam treatment. Canadian Veterinary Journal, 50(5), 506–510.
Szczubiał, M., Dabrowski, R., Łopuszyński, W., Bochniarz, M., & Krawczyk, M. (2018). Changes in serum neopterin and C-reactive protein concentrations in female dogs with mammary gland tumours. Polish Journal of Veterinary Sciences, 21(4), 691–696.
Tecles F., Caldín M., Zanella A., Membiela F., Tvarijonaviciute A., Subiela S. M., & Cerón J. J. (2009). Serum acute phase protein concentrations in female dogs with mammary tumors. Journal of Veterinary Internal Medicine, 21(2), 214-219.
Valencakova-Agyagosova, A., Frischova, Z., Sevcikova, Z., Hajurka, J., Lepej, J., Szakallova, I., Kredatusova, G., Nagy, V., & Ledecky, V. (2014). Determination of carcinoembryonic antigen and cancer antigen (CA 15-3) in bitches with tumours on mammary gland: Preliminary report. Veterinary and Comparative Oncology, 12(3), 205–214.
Vascellari, M., Capello, K., Carminato, A., Zanardello, C., Baioni, E., & Mutinelli, F. (2016). Incidence of mammary tumors in the canine population living in the Veneto region (Northeastern Italy): Risk factors and similarities to human breast cancer. Preventive Veterinary Medicine, 126, 183–189.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Breno Queiroz Pinheiro; Hélida Tainan Silva Barbosa; Manoel Wanamark David Ferreira Filho ; Gabriel Rocha Gurgel ; Francisco Wesley da Silva Alves ; Isaac Neto Goes da Silva; Lúcia Daniel Machado da Silva
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
